The Relationship Between GBS Screening in Pregnant Women Insured in Maccabi Healthcare Services (MHS) and Early-onset Neonatal Disease in Israel
Completed
- Conditions
- Streptococcal Infection Group B as Cause of Diseases Classified Elsewhere (Diagnosis)
- Registration Number
- NCT04222907
- Lead Sponsor
- Assuta Hospital Systems
- Brief Summary
Determination of GBS colonization rates in Pregnant Women insured with Maccabi Health Services, Doctors' Compliance Rates for Referral for Testing, test execution rates, and Early-onset GBS Disease (EOGBSD) Rates in Israel. Determine the relationship between conducting a GBS test in pregnant women and EOGBSD in Israel.
- Detailed Description
There have been few studies in recent years, which has prompted us to undertake this study. Our aim was to examine the current colonization rates and attack rates in the Israeli population. Our secondary aim was to evaluate the need to readjust recommendations towards universal screening.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 54759
Inclusion Criteria
- All women with term pregnancies from 2015 to 2016 (until 20/9/16) insured by Maccabi Healthcare Services (MHS)
Exclusion Criteria
- repeat pregnancies occurring in the same woman during the time period
- multiple pregnancies
- gestational age greater than 42 weeks due to probability of data inaccuracy
- women with missing information
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Attack rate of early-onset GBS disease (EOGBSD) 2015-2016 Attack rate of (EOGBSD)
- Secondary Outcome Measures
Name Time Method